APTAMER GROUP PLC Logo

APTAMER GROUP PLC

Develops custom aptamer-based binders as antibody alternatives for life science applications.

APTA | IL

Overview

Corporate Details

ISIN(s):
GB00BNRRP542
LEI:
213800Y4XGH3WJNBE686
Country:
United Kingdom
Address:
WINDMILL HOUSE, YO10 5BR YORK
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Aptamer Group PLC is a leading developer of custom affinity binders for the life sciences industry through its proprietary Optimer® platform. Optimer binders are next-generation, aptamer-based synthetic ligands engineered to provide high affinity, specificity, and stability. The company offers custom discovery and development services, delivering innovative solutions that serve as alternatives to traditional binders like antibodies. These solutions are utilized across a wide range of applications, including therapeutics, diagnostics, research, and bioprocessing, supporting a global client base of biotechnology and pharmaceutical companies.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for APTAMER GROUP PLC and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-11 08:00
Regulatory News Service
New contract with Metir plc
English 17.0 KB
2025-09-09 08:00
Director's Dealing
Notification of dealings by a director/PDMR
English 23.8 KB
2025-09-02 08:00
Regulatory News Service
Therapeutic development agreement with Invizius
English 18.4 KB
2025-08-28 08:00
Share Issue/Capital Change
Block Listing Interim Review
English 14.9 KB
2025-08-22 08:00
Regulatory News Service
Update on licensing and development progress
English 19.5 KB
2025-08-19 08:00
Share Issue/Capital Change
Exercise of warrants
English 13.5 KB
2025-08-18 08:00
Regulatory News Service
Contract extension with global pharma partner
English 14.7 KB
2025-08-08 08:00
Report Publication Announcement
Investor Technical Webinar
English 13.0 KB
2025-08-07 18:24
Declaration of Voting Results & Voting Rights Announcements
Holding(s) in Company
English 52.2 KB
2025-08-05 09:05
Major Shareholding Notification
Holding(s) in Company
English 22.0 KB
2025-07-31 14:29
Regulatory News Service
Investor Webinar
English 13.7 KB
2025-07-31 08:00
Earnings Release
Trading Update
English 21.0 KB
2025-07-28 13:25
Major Shareholding Notification
Holding(s) in Company
English 52.1 KB
2025-07-24 12:48
Post-Annual General Meeting Information
Result of General Meeting
English 12.4 KB
2025-07-21 08:00
Regulatory News Service
Additional work commissioned by Unilever
English 14.6 KB

Automate Your Workflow. Get a real-time feed of all APTAMER GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for APTAMER GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Spago Nanomedical AB Logo
Develops nanomedicine for precision MRI tumor diagnostics and targeted cancer radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Developing first-in-class macrocyclic drugs for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops and out-licenses preclinical cancer drug programs using fragment-based discovery.
Sweden SPRINT
Stayble Therapeutics AB Logo
Develops an injectable therapy for disc-related spinal disorders as an alternative to surgery.
Sweden STABL
Stem Cells Spin Spolka Akcyjna Logo
Commercializes patented MIC-1 stem cell technology for regenerative medicine.
Poland SCS
STRIX GROUP PLC Logo Isle of Man KETL
SynAct Pharma Logo
Developing oral resolution therapies for inflammatory diseases like rheumatoid arthritis.
Sweden SYNACT
SYNAIRGEN PLC Logo
Develops an inhaled interferon beta therapy for severe viral lung infections.
United Kingdom SNG
Terranet B Logo
Develops ultra-fast ADAS anti-collision technology for automakers to protect vulnerable road users.
Sweden TERRNT
Israel TMIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.